Emerging Innovations in Translational Medicine: An Interview with Marcie Glicksman, Enclear Therapies
3D cultures and organ-on-a-chip are a few examples of technologies that hope to bridge the gap from benchside to clinic. Failures that arise during drug development often arise due to poor translatability from models in preclinical studies to the patients...
4 years agoEmerging Innovations in Translational Medicine: An Interview with Marcie Glicksman, Enclear Therapies
3D cultures and organ-on-a-chip are a few examples of technologies that hope to bridge the gap from benchside to clinic. Failures that arise during drug development often arise due to poor translatability from models in preclinical studies to the patients...
4 years agoDrugs in Space: How Extraterrestrial Experiments Help Us Develop Medicine
Over the last 20 years, fundamental scientific research has been conducted by astronauts aboard the international space station (ISS). It has only been recently that the pharmaceutical and biotech sectors have invested in extraterrestrial experiments, hoping to find novel ways...
4 years agoDrugs in Space: How Extraterrestrial Experiments Help Us Develop Medicine
Over the last 20 years, fundamental scientific research has been conducted by astronauts aboard the international space station (ISS). It has only been recently that the pharmaceutical and biotech sectors have invested in extraterrestrial experiments, hoping to find novel ways...
4 years agoCOVID’s Impact on Innovations in Regulatory Affairs
While the impact of COVID-19 was significant in every area of the pharmaceutical sector, some of the most pandemic’s most overlooked impacts were within the regulatory space. From study design to submissions, the virus affected every aspect of drug regulation,...
4 years agoCOVID’s Impact on Innovations in Regulatory Affairs
While the impact of COVID-19 was significant in every area of the pharmaceutical sector, some of the most pandemic’s most overlooked impacts were within the regulatory space. From study design to submissions, the virus affected every aspect of drug regulation,...
4 years agoHow Predictive Modelling Can Change Personalised Medicine
Personalised medicine - treatments which focus on the individual patient or sub-population, not simply prescribing a generic treatment to a large swathe of patients - has been a key target in healthcare for a long time now. New technologies, including...
4 years agoHow Predictive Modelling Can Change Personalised Medicine
Personalised medicine - treatments which focus on the individual patient or sub-population, not simply prescribing a generic treatment to a large swathe of patients - has been a key target in healthcare for a long time now. New technologies, including...
4 years agoCOVID-19 Booster Controversy: Disputes Across the Pharma Industry
Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and...
4 years agoCOVID-19 Booster Controversy: Disputes Across the Pharma Industry
Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and...
4 years agoAddressing the Challenges of CNS Drug Delivery
Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....
4 years agoAddressing the Challenges of CNS Drug Delivery
Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....
4 years ago